Table 2. The basic demographic and epidemiological characteristics of the 78 enrolled patients with recent-onset atrial fibrillation, randomly allocated into group A (cardioversion by intravenous administration of vernakalant) and group B (cardioversion by intravenous administration of ibutilide).

Values are given as numbers (percentage in brackets) or means ± standard deviation, AF: atrial fibrillation, CAD: coronary artery disease, EF: ejection fraction.